Filter
404
Text search:
Guinée
Featured
Recommendations
38
New Publications
172
Language
Document type
No document type
299
Guidelines
25
Studies & Reports
22
Infographics
15
Fact sheets
13
Videos
6
Manuals
5
Training Material
5
Strategic & Response Plan
4
Brochures
3
Online Courses
3
Situation Updates
2
Resource Platforms
2
Countries / Regions
Guinea
315
Sierra Leone
146
Liberia
143
Senegal
112
Burkina Faso
102
Mali
97
Congo, Democratic Republic of
92
Côte d’Ivoire / Ivory Coast
91
Guinea-Bissau
84
Mozambique
50
Angola
49
Chad
47
Nigeria
42
Niger
40
Cameroon
28
Ghana
26
Brazil
21
Ethiopia
20
Rwanda
14
Papua New Guinea
14
Kenya
11
West and Central Africa
11
Togo
8
Uganda
7
Egypt
7
Benin
6
Central African Republic
5
Zimbabwe
4
Somalia
3
Afghanistan
3
Gambia
3
Malawi
3
Burundi
3
Madagascar
3
Portugal
3
Pakistan
2
Iraq
2
Zambia
2
Tanzania
2
Indonesia
2
Eswatini/ Swaziland
2
Cape Verde
2
Lesotho
2
Africa
2
Djibouti
2
Russia
2
France
2
USA
1
Haiti
1
Philippines
1
South Sudan
1
Lebanon
1
Mauritania
1
South Africa
1
Sudan
1
Vanuatu
1
Namibia
1
Ukraine
1
Botswana
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Latin America and the Carribbean
1
Luxembourg
1
Solomon Islands
1
North Korea
1
Congo-Brazzaville
1
Canada
1
Iran
1
Global
1
Gabon
1
Belgium
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
89
Clinical Guidelines
15
Key Resources
13
Women & Child Health
8
Capacity Building
5
Public Health
3
Pharmacy & Technologies
1
Toolboxes
Ebola
284
COVID-19
50
Rapid Response
14
Cholera
4
Caregiver
4
Polio
3
HIV
3
Pharmacy
3
Natural Hazards
1
Refugee
1
TB
1
Global Health Education
1
AMR
1
Planetary Health
1
NTDs
1
NCDs
1
Estigma Social associado à COVID-19
recommended
Um guia para prevenir e combater o estigma social
Health workers participating in pandemic response are exposed to many different occupational risks to health and safety. These include: COVID-19 infection, illness, and transmission to others; fatigue from working longer hours and heavy workload, insufficient sleep or rest, dehydration, and inadequa
...
A Estratégia Conjunta Continental Africana para a COVID-19 é sustentada pela necessidade de limitar a transmissão, prevenir mortes e reduzir os danos associados. A participação das nações africanas em ensaios clínicos é um passo essencial para garantir que sejam gerados dados suficientes so
...
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
Os itens neste catálogo representam uma seleção prioritária inicial e estão sujeitos a revisões constantes. Nada neste catálogo deve ser interpretado como oferta ou garantia de alocação de suprimentos. Os custos dos itens são apenas estimativas.
Applying the evidence of what works from HIV-related stigma and discrimination in six settings to the COVID-19 response
This brief provide evidence-informed guidance to countries on the intersection of stigma related to HIV and COVID-19 in national responses.
Série de documentos de informação sintéticos do Escritório Regional da OMS para a África sobre a COVID-19 :10.ª série: a COVID-19 e tuberculose
medPPE é um aplicativo para dispositivos iOS e Android em que o trabalhador de saúde encontrará as informações necessárias sobre equipamentos de proteção individual (EPI) sugeridos pela OPAS/OMS, que devem ser utilizadas de acordo com o papel e atividade que desempenha no cuidado de paciente
...
Health Situation
Health policies and systems
Cooperation for Health
WHO Country Cooperation Strategic Agenda (2008-2013)
Stock-outs of antimalarials cause unnecessary deaths among an estimated 219 million people afflicted worldwide. Good pharmaceutical information systems can avoid stock-outs with timely, accurate data and high reporting rates that ensure the continuous availability of critically-needed antimalarials.
...
Mars 2020. Recommendations selon les differentes phases
12 January 2021
The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.